Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

C. S. Ranucci; T. Tagmyer; P. Duncan

doi:10.5731/pdajpst.2011.00827

OtherConference Proceeding

Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

C. S. Ranucci, T. Tagmyer and P. Duncan

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 589-598; DOI: https://doi.org/10.5731/pdajpst.2011.00827

C. S. Ranucci

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: colette.ranucci@merck.com

T. Tagmyer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

P. Duncan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 65 no. 6 589-598

DOI

https://doi.org/10.5731/pdajpst.2011.00827

PubMed

22294581

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online January 4, 2012.

Author Information

C. S. Ranucci1,*,
T. Tagmyer1 and
P. Duncan2

¹Vaccine Manufacturing Science and Commercialization and
²Bioprocess Research and Development, Merck & Co., Inc. West Point, PA

↵* Corresponding author: WP17-101, 770 Sumneytown Pike, P. O. Box 4, West Point, PA 19486. E-mail: colette.ranucci{at}merck.com.

View Full Text

Cited By...

13 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Rotavirus vaccination in Europe: drivers and barriers

N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, P Van Damme, T Vesikari

The Lancet Infectious Diseases 2014 14 5
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine,Rotarix™

Gary Dubin, Jean-François Toussaint, Jean-Pol Cassart, Barbara Howe, Donna Boyce, Leonard Friedland, Remon Abu-Elyazeed, Sylviane Poncelet, Htay Htay Han, Serge Debrus

Human Vaccines & Immunotherapeutics 2013 9 11
Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq®

Mathew D Esona, Slavica Mijatovic-Rustempasic, Catherine Yen, Umesh D Parashar, Jon R Gentsch, Michael D Bowen, Philip LaRussa

Human Vaccines & Immunotherapeutics 2014 10 1
Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine

Cornelia Lackner, Sandra M. Leydold, Jens Modrof, Maria R. Farcet, Leopold Grillberger, Birgit Schäfer, Heinz Anderle, Thomas R. Kreil

Vaccine 2014 32 18
Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis

Htay Htay Han, Naveen Karkada, Girish Jayadeva, Gary Dubin

Human Vaccines & Immunotherapeutics 2017 13 1
The Rotavirus Saga Revisited

Alan R. Shaw

Annual Review of Medicine 2013 64 1
Screening of Viral Pathogens from Pediatric Ileal Tissue Samples after Vaccination

Laura Hewitson, James B. Thissen, Shea N. Gardner, Kevin S. McLoughlin, Margaret K. Glausser, Crystal J. Jaing

Advances in Virology 2014 2014
Review: High temperature short time treatment of cell culture media and feed solutions to mitigate adventitious viral contamination in the biopharmaceutical industry

Leïla Djemal, Clemence Fournier, Joerg von Hagen, Harald Kolmar, Véronique Deparis

Biotechnology Progress 2021 37 3
Viral Gastroenteritis

T. Vesikari

2016
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Philip R. Dormitzer

2015
Feigin and Cherry's Textbook of Pediatric Infectious Diseases

Timo Vesikari, Lennart Svensson, Marie Hagbom

2025
Fundamentals of Biologicals Regulation

Rebecca Sheets

2018
Fundamentals of Biologicals Regulation

Rebecca Sheets

2018

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 65, Issue 6

November/December 2011

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 3 + 14 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

C. S. Ranucci, T. Tagmyer, P. Duncan

PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 589-598; DOI: 10.5731/pdajpst.2011.00827

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

C. S. Ranucci, T. Tagmyer, P. Duncan

PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 589-598; DOI: 10.5731/pdajpst.2011.00827

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Conference Proceeding

Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations–Purification Unit Operations
Proceedings of the 2017 Viral Clearance Symposium—
Proceedings of the 2017 Viral Clearance Symposium, Session 4: Submission Strategies

Show more Conference Proceeding

Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
Case Study of Apparent Virus Contamination in Biopharmaceutical Product at Centocor
Identification and Remediation of a Cell Culture Virus Contamination

Show more Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

Paper

Evolution of Approaches to Viral Safety Issues for Biological Products
Broadening Our Expectations for Viral Safety Risk Mitigation

Show more Paper

Main menu

User menu

Search

Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Conference Proceeding

Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

Paper

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.